Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
Endonovo Therapeutics (ENDV) Financial Statements
17 Followers
Endonovo Therapeutics Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.52K | $ 45.20K | $ 87.54K | $ -13.91M | $ 10.96K |
| Gross Profit | $ 693.00 | $ 45.20K | $ 83.54K | $ -13.91M | $ 6.93K |
| EBIT | $ -480.28K | $ 2.38M | $ 7.54M | $ -14.47M | $ -264.79K |
| EBITDA | $ -318.55K | $ 2.54M | $ 7.70M | $ -14.29M | $ -103.06K |
| Net Income Common Stockholders | $ -766.17K | $ 2.06M | $ 438.26K | $ -12.93M | $ -603.36K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 0.00 | $ 32.60K | $ 10.94K | $ 98.00 | $ 23.14K |
| Total Assets | $ 815.76K | $ 1.01M | $ 1.20M | $ 1.28M | $ 1.45M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 7.15M | $ 7.24M |
| Net Debt | $ 0.00 | $ -32.60K | $ -10.94K | $ 7.15M | $ 7.22M |
| Total Liabilities | $ 23.78M | $ 23.22M | $ 25.57M | $ 33.46M | $ 21.06M |
| Stockholders Equity | $ -22.96M | $ -22.20M | $ -24.37M | $ -32.18M | $ -19.61M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -100.00K | $ -165.84K | $ -173.16K | $ -178.84K | $ -123.86K |
| Operating Cash Flow | $ -100.00K | $ -165.84K | $ -173.16K | $ -178.84K | $ -123.86K |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | $ 32.77K | $ 187.50K | $ 184.00K | $ 202.50K | $ 147.00K |
Endonovo Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.